Clinical Trial Update: Anti-inflammatory Status in DM2 Treated Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating anti-inflammatory status in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Catanzaro | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN